Lipidomic Predictors of Coronary No-Reflow
Metabolites · 03.01.2023 · 13 (1) · 79
DOI: 10.3390/metabo13010079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 03.01.2023. Verfasst von Arun Surendran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Lipidomics Laboratory, St. Boniface Hospital, Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St. Boniface Hospital Foundation and Manitoba Cardiac Sciences Program, Research Manitoba Master's Studentship (2018), Bank of Montreal/Institute of Cardiovascular Sciences Studentship (2019).
Abstract (Originalsprache)
The ‘no-reflow’ phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is a serious complication among acute ST-segment elevation myocardial infarction (STEMI) patients. Herein, a comprehensive lipidomics approach was used to quantify over 300 distinct molecular species in circulating plasma from 126 patients with STEMI before and after primary PCI. Our analysis showed that three lipid classes: phosphatidylcholine (PC), alkylphosphatidylcholine (PC(O)), and sphingomyelin (SM), were significantly elevated (p < 0.05) in no-reflow patients before primary PCI. The levels of individual fatty acids and total fatty acid levels were significantly lower (p < 0.05) in no-reflow subjects after PCI. The grouping of patients based on ECG ST-segment resolution (STR) also demonstrated the same trend, confirming the possible role of these differential lipids in the setting of no-reflow. Sphingomyelin species, SM 41:1 and SM 41:2, was invariably positively correlated with corrected TIMI frame count (CTFC) at pre-PCI and post-PCI. The plasma levels of SM 42:1 exhibited an inverse association (p < 0.05) consistently with tumor necrosis factor-alpha (TNF-α) at pre-PCI and post-PCI. In conclusion, we identified plasma lipid profiles that distinguish individuals at risk of no-reflow and provided novel insights into how dyslipidemia may contribute to NRP after primary PCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Lipidomics Laboratory, St. Boniface Hospital, Albrechtsen Research Centre, Winnipeg, MB R2H 2A6, Canada.
- Mass Spectrometry and Proteomics Core Facility, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, Kerala, India.
- Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
- Section of Cardiology, Department of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72204, USA.
- Faculty of Agricultural and Food Sciences, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
ORCID-Profile: Amir Ravandi
Förderung
- St. Boniface Hospital Foundation and Manitoba Cardiac Sciences Program
- Research Manitoba Master's Studentship (2018)
- Bank of Montreal/Institute of Cardiovascular Sciences Studentship (2019)
- Singal Graduate Scholarship in Cardiovascular Sciences (2019)
- Research Manitoba Master’s Studentship (2018)
Zitieren
APA
Surendran, A., Ismail, U., Atefi, N., Bagchi, A. K., Singal, P. K., Shah, A., Aliani, M., & Ravandi, A. (2023). Lipidomic Predictors of Coronary No-Reflow. Metabolites, 13(1), 79. https://doi.org/10.3390/metabo13010079
Vancouver
Surendran A, Ismail U, Atefi N, Bagchi AK, Singal PK, Shah A, et al. Lipidomic Predictors of Coronary No-Reflow. Metabolites. 2023;13(1):79. doi:10.3390/metabo13010079
BibTeX
@article{Surendran2023,
author = {Surendran, Arun and Ismail, Umar and Atefi, Negar and Bagchi, Ashim K and Singal, Pawan K and Shah, Ashish and Aliani, Michel and Ravandi, Amir},
title = {Lipidomic Predictors of Coronary No-Reflow},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {1},
pages = {79},
doi = {10.3390/metabo13010079}
}
EUVIMED